Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

Overview of attention for article published in Annals of Internal Medicine, February 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

policy: 1 policy source

guideline: 5 clinical guideline sources

Readers on

mendeley: 180 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

So far, Altmetric has seen 1 policy document that references this research output.

Monitoring for renal renal toxicity in people receiving tenofovir and on tenofovir toxicity and how it affects disability-adjusted life-years and quality-adjusted life-years

Cited by World Health Organization (WHO) on 30 Jun 2014

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.